Zoetis (ZTS)
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-07-08
$76.29+1.15%
Close 2026-07-07 · 1-day change
Reading ZTS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ZTS free→NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-07-08
Reading ZTS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ZTS free→QuarterlyIQ Insights · ZTS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | 9,531.0 | 9,467.0 | 9,256.0 | 8,544.0 | 8,080.0 | 7,776.0 | 6,675.0 | 6,260.0 | 4,888.0 | 4,888.0 | 4,888.0 | 4,765.0 | 4,336.0 |
| Total Revenues | 9,531.0 | 9,467.0 | 9,256.0 | 8,544.0 | 8,080.0 | 7,776.0 | 6,675.0 | 6,260.0 | 4,888.0 | 4,888.0 | 4,888.0 | 4,765.0 | 4,336.0 |
| Cost of Revenues | 2,689.0 | 2,666.0 | 2,719.0 | 2,561.0 | 2,454.0 | 2,303.0 | 2,057.0 | 1,992.0 | 1,666.0 | 1,666.0 | 1,666.0 | 1,738.0 | 1,563.0 |
| Operating Expenses & Income | |||||||||||||
| Selling, General & Admin | 2,392.0 | 2,378.0 | 2,318.0 | 2,151.0 | 2,009.0 | 2,001.0 | 1,726.0 | 1,638.0 | 1,364.0 | 1,364.0 | 1,364.0 | 1,532.0 | 1,470.0 |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | — | — | — | 46.0 |
| Operating Income | 3,345.0 | 3,360.0 | 3,133.0 | 2,936.0 | 2,656.0 | 2,488.0 | 1,996.0 | 1,801.0 | 1,228.0 | 1,228.0 | 1,228.0 | 545.0 | 710.0 |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | 230.0 | 222.0 | 225.0 | 239.0 | 221.0 | 224.0 | 231.0 | 223.0 | 166.0 | 166.0 | 166.0 | 124.0 | 31.0 |
| Other Non-Operating Income / Expenses | 41.0 | 36.0 | 19.0 | 159.0 | (40.0) | (48.0) | (17.0) | 57.0 | 2.0 | 2.0 | 2.0 | (81.0) | 46.0 |
| Asset Writedown | 45.0 | 47.0 | 31.0 | 46.0 | 53.0 | 47.0 | 43.0 | 7.0 | 5.0 | 5.0 | 5.0 | 60.0 | 10.0 |
| EBT, Incl. Unusual Items | 3,345.0 | 3,360.0 | 3,133.0 | 2,936.0 | 2,656.0 | 2,488.0 | 1,996.0 | 1,801.0 | 1,228.0 | 1,228.0 | 1,228.0 | 545.0 | 710.0 |
| Income Tax Expense | 673.0 | 687.0 | 637.0 | 596.0 | 545.0 | 454.0 | 360.0 | 301.0 | 409.0 | 409.0 | 409.0 | 206.0 | 274.0 |
| Net Income | |||||||||||||
| Minority Interest | 0.0 | 0.0 | 10.0 | (4.0) | (3.0) | (3.0) | (2.0) | 0.0 | (2.0) | (2.0) | (2.0) | 0.0 | 0.0 |
| Net Income | 2,672.0 | 2,673.0 | 2,486.0 | 2,344.0 | 2,114.0 | 2,037.0 | 1,638.0 | 1,500.0 | 821.0 | 821.0 | 821.0 | 339.0 | 436.0 |
| Per Share | |||||||||||||
| Basic EPS | 6.33 | 6.03 | 5.47 | 5.08 | 4.51 | 4.29 | 3.44 | 3.14 | 1.66 | 1.66 | 1.66 | 0.68 | 0.87 |
| Diluted EPS | 6.33 | 6.02 | 5.47 | 5.07 | 4.49 | 4.27 | 3.42 | 3.11 | 1.65 | 1.65 | 1.65 | 0.68 | 0.87 |
| Revenue per Share | 22.56 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 422.1 | 443.4 | 454.2 | 461.2 | 468.9 | 474.3 | 475.5 | 478.1 | 495.7 | 495.7 | 495.7 | 499.7 | 500.0 |
| Diluted Weighted Avg Shares | 422.4 | 443.8 | 454.8 | 462.3 | 470.4 | 476.7 | 478.6 | 481.8 | 498.2 | 498.2 | 498.2 | 502.0 | 500.0 |
| Supplemental | |||||||||||||
| EBITDA | — | 3,847.0 | 3,630.0 | 3,427.0 | 3,121.0 | 2,936.0 | 2,437.0 | 2,213.0 | 1,468.0 | 1,468.0 | 1,468.0 | 744.0 | 910.0 |
| EBIT | 3,345.0 | 3,360.0 | 3,133.0 | 2,936.0 | 2,656.0 | 2,488.0 | 1,996.0 | 1,801.0 | 1,228.0 | 1,228.0 | 1,228.0 | 545.0 | 710.0 |
| Effective Tax Rate | 20.1% | 20.4% | 20.3% | 20.3% | 20.5% | 18.2% | 18.0% | 16.7% | 33.3% | 33.3% | 33.3% | 37.8% | 38.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.